Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
Símbolo de cotizaciónSRTS
Nombre de la empresaSensus Healthcare Inc
Fecha de salida a bolsaJun 03, 2016
Director ejecutivoMr. Joseph C. Sardano
Número de empleados35
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 03
Dirección851 Broken Sound Pkwy NW Ste 215
CiudadBOCA RATON
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal33487-3635
Teléfono15619225808
Sitio Webhttps://sensushealthcare.com/
Símbolo de cotizaciónSRTS
Fecha de salida a bolsaJun 03, 2016
Director ejecutivoMr. Joseph C. Sardano
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos